{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-002369","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2025-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.120870+00:00","generated_at":"2026-05-23T09:20:11.206974+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Profound Medical releases proxy circular for May 14, 2025 annual meeting","bullets":["Annual and special meeting scheduled for May 14, 2025; record date April 4, 2025.","Shareholders to vote on election of six directors, auditor appointment, and approval of unallocated stock options.","Neil Gagnon beneficially owns 11.2% of outstanding common shares.","CEO Arun Menawat beneficially owns 1.88% of shares and 28.2% of options."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-002369","json":"https://secwatch.observer/filing/0001171843-25-002369.json","markdown":"https://secwatch.observer/filing/0001171843-25-002369.md","text":"https://secwatch.observer/filing/0001171843-25-002369.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325002369/0001171843-25-002369-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325002369/f8k_042225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T09:20:11.206974+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}